2016
DOI: 10.1016/j.biopha.2016.09.020
|View full text |Cite
|
Sign up to set email alerts
|

Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
68
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 105 publications
(73 citation statements)
references
References 43 publications
5
68
0
Order By: Relevance
“…Modulation of macrophage subtypes is a promising therapeutic approach in the treatment of many inflammatory diseases such as ALI/ARDS. In the LPS‐induced murine ALI model, Res can effectively attenuate the severity of ALI, and the beneficial effects are associated with lower NLRP3 inflammasome activation and release of IL‐1beta and IL‐18 . However, whether Res suppresses ALI through modulation of macrophage subtypes and whether STAT3/SOCS3 signalling is involved in the therapeutic effects remains unknown.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Modulation of macrophage subtypes is a promising therapeutic approach in the treatment of many inflammatory diseases such as ALI/ARDS. In the LPS‐induced murine ALI model, Res can effectively attenuate the severity of ALI, and the beneficial effects are associated with lower NLRP3 inflammasome activation and release of IL‐1beta and IL‐18 . However, whether Res suppresses ALI through modulation of macrophage subtypes and whether STAT3/SOCS3 signalling is involved in the therapeutic effects remains unknown.…”
Section: Discussionmentioning
confidence: 99%
“…Res or Res‐curcumin hybrids can significantly attenuate disease severity of ALI, accompanied with lower production of pro‐inflammatory cytokines and chemokines, such as TNF‐alpha, IL‐1beta, IL‐6, IL‐12, IL‐33, MIP‐2 and IL‐18. In contrast, the anti‐inflammatory cytokines and molecular mediators, such as IL‐10, heme oxygenase‐1 (HO‐1),Nrf2 (nuclear factor‐erythroid 2 related factor) and SOD (superoxide dismutase), were increased in the Res‐treated animal models . The beneficial effects may be associated with up‐regulation and activation of SIRT1, a nicotinamide adenine dinucleotide (NAD+‐dependent deacetylase sirtuin 1) .…”
Section: Introductionmentioning
confidence: 99%
“…In response to ROS, Txnip detaches from thioredoxin (Trx), which is composed of two isoforms, including the cytosolic Trx-1 and mitochondrial Trx-2, and binds to nucleotide-binding domain-like receptor protein 3 (NLRP3), resulting in NLRP3 inflammasome activation [16], [17]. Activation of NLRP3 inflammasome, including NOD like receptor, NLRP3 protein, the adaptor ASC protein and caspase-1, result in the maturation and release of pro-inflammatory cytokines, IL-1β and IL-18 which also plays a significant role in the development of ALI [18], [19].…”
Section: Introductionmentioning
confidence: 99%
“…These effects of NR and NMN appear to be largely mediated by SIRT1 and/ or SIRT3 [117, 121, 124]. Not surprisingly, resveratrol, the polyphenol present in the skin of grapes, another sirtuin activator, also inhibits NLRP3 inflammasome activation in mice by preserving mitochondrial function, and protects against hepatosteatosis, renal inflammation and LPS-induced lung injury [125127]. Interestingly, recent evidence suggests that resveratrol activates sirtuins indirectly by increasing NAD + levels in an AMPK-dependent manner [128].…”
Section: Strategies and Therapeutics To Inhibit The Nlrp3 Inflammasomementioning
confidence: 99%